לייף- מסקרה בצבע שחור עמוק לריסים מודגשים במיוחד נבדק אופטלמולוגית
דניה קוסמטיקס בעמ -
דולוקסטין אס.קיי. 30 מג
k.s.kim international (sk- pharma) ltd., israel - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine
דולוקסטין אס.קיי. 60 מג
k.s.kim international (sk- pharma) ltd., israel - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine
דימתיל פומרט דקסל 120 מג
dexcel ltd, israel - dimethyl fumarate - dimethyl fumarate 120 mg - dimethyl fumarate
דימתיל פומרט דקסל 240 מג
dexcel ltd, israel - dimethyl fumarate - dimethyl fumarate 240 mg - dimethyl fumarate
מקרילן
megapharm ltd - macimorelin as acetate - macimorelin as acetate 60 mg - macimorelin
מידולם 5 מגמל
rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 5 mg/ml - midazolam - midazolam - premedication befor induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration).status epilepticus.
דסמופרסין טבע 0.1 מג
teva israel ltd - desmopressin acetate - טבליה - desmopressin acetate 0.1 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.
דסמופרסין טבע 0.2 מג
teva israel ltd - desmopressin acetate - טבליה - desmopressin acetate 0.2 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.